Wealth Enhancement Advisory Services’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.98M	Sell	11,692 -9,788	-46%	-$2.44M	0.01%	1183
2025 Q4	$6.03M	Sell	21,480 -7,693	-26%	-$2.1M	0.01%	929
2025 Q3	$7.76M	Buy	29,173 +2,621	+10%	+$637K	0.01%	749
2025 Q2	$5.9M	Sell	26,552 -1,382	-5%	-$295K	0.01%	833
2025 Q1	$6.25M	Sell	27,934 -2,318	-8%	-$639K	0.01%	742
2024 Q4	$9.91M	Sell	30,252 -1,375	-4%	-$433K	0.02%	557
2024 Q3	$9.49M	Sell	31,627 -642	-2%	-$197K	0.02%	530
2024 Q2	$10.6M	Sell	32,269 -4,493	-12%	-$1.59M	0.03%	475
2024 Q1	$14.5M	Sell	36,762 -303	-0.8%	-$112K	0.04%	381
2023 Q4	$13.1M	Buy	37,065 +105	+0.3%	+$37.2K	0.04%	375
2023 Q3	$13.9M	Buy	+36,960	New	+$14.3M	0.05%	342
2022 Q4	–	Sell	-6,378	Closed	-$1.59M	–	376
2022 Q3	$1.59M	Buy	6,378 +2,613	+69%	+$796K	0.02%	190
2022 Q2	$1.2M	Buy	+3,765	New	+$1.23M	0.02%	238
2021 Q3	–	Sell	-4,099	Closed	-$1.52M	–	347
2021 Q2	$1.52M	Buy	4,099 +514	+14%	+$170K	0.02%	154
2021 Q1	$1.04M	Buy	3,585 +141	+4%	+$40.4K	0.02%	195
2020 Q4	$1.03M	Buy	+3,444	New	+$966K	0.02%	164
2020 Q3	–	Sell	-6,021	Closed	-$1.54M	–	248
2020 Q2	$1.54M	Buy	+6,021	New	+$1.18M	0.04%	141